S&P 500 edges higher, Nasdaq dips in choppy session as inflation data eyed

By Chuck Mikolajczak

NEW YORK (Reuters) -The S&P 500 edged higher while the Nasdaq dipped after a volatile session on Tuesday as investors gauged inflation data and braced for quarterly earnings reports to justify stock valuations and the strength of the U.S. economy.

Stocks oscillated between gains and losses throughout the day. Equities received an initial lift from a Labor Department report that showed the producer price index rose less than expected in December, although the report failed to materially affect expectations about the Federal Reserve's likely path of monetary policy this year.

Investors awaited Wednesday's consumer price index reading, which will further shape expectations for inflation and the Fed.

"There is an inherent level of uncertainty out there about where rates and the Fed is headed," said Chris Fasciano, chief market strategist at Commonwealth Financial Network.

"Now we'll see what tomorrow morning brings," he said, referring to the CPI report.

The Dow Jones Industrial Average rose 221.16 points, or 0.52%, to 42,518.28, the S&P 500 gained 6.69 points, or 0.11%, to 5,842.91 and the Nasdaq Composite lost 43.71 points, or 0.23%, to 19,044.39.

The market is pricing in about 29 basis points in rate cuts from the Fed by the end of 2025, according to LSEG data, with expectations for a cut of at least 25 bps not rising above 50% until the June meeting.

Adding to investor caution, U.S. Treasury yields remained at elevated levels, with the yield on the benchmark 10-year Treasury note at 4.784%, holding near a 14-month high reached on Monday.

Quarterly earnings get under way on Wednesday with results from big banks, which are expected to post stronger profits, fueled by robust dealmaking and trading. The S&P 500 bank index advanced.

Goldman Sachs shares gained 1.52% ahead of its earnings results scheduled for Wednesday and helped keep the Dow in positive territory.

The benchmark S&P 500 is trading at valuations well above its historical long-term average and a disappointing earnings season could put further gains for equities in jeopardy.

Healthcare was among the worst-performing of the 11 major S&P sectors, down 0.94% as Eli Lilly stumbled 6.59% after it forecast fourth-quarter sales of weight-loss drug Zepbound below estimates.

Kansas City Fed president Jeff Schmid said the impact of Trump's policies was an "active conversation" at the central bank and that it would respond if either its inflation or employment goals are pushed off course.

After rallying following the U.S. election, stocks have struggled recently, with the S&P 500 falling in four of the previous five weeks as a resilient economy, nagging inflation and comments from Fed policymakers have fueled worries about the central bank being less aggressive in cutting interest rates than previously anticipated.

Concerns about potential tariffs from the Trump administration that would further stoke inflation have also lingered.

Boeing shed 2.08% after the planemaker's annual deliveries dropped in 2024 to their lowest level since the pandemic.

Advancing issues outnumbered decliners by a 2.81-to-1 ratio on the NYSE and by a 1.39-to-1 ratio on the Nasdaq.

The S&P 500 posted eight new 52-week highs and six new lows, while the Nasdaq Composite recorded 36 new highs and 132 new lows.

Volume on U.S. exchanges was 13.58 billion shares, compared with the 15.72-billion average over the last 20 trading days.

(Reporting by Chuck Mikolajczak, additional reporting by Sin?ad Carew in New York, Johann M Cherian and Sukriti Gupta in Bengaluru; Editing by Rod Nickel)